NASDAQ Companies

IND clearance for GTB-3650, a 2ndgeneration nanobody TriKE®for treatment of CD33+ leukemia expected in Q2 2024 Phase 1 trial initiation […]

SAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) —  Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that on May 10, 2024, […]

LOS ANGELES, May 15, 2024 (GLOBE NEWSWIRE) — NASDAQ-listed, AGBA Group Holding Limited (“AGBA” or the “Company” or the “Group”), […]

• Posts Adjusted EBITDA Margin of 23.3% as a % of Revenue • Announced Normal Course Issuer Bid (“NCIB”) Subsequent to […]

Or Yehuda, Israel, May 15, 2024 (GLOBE NEWSWIRE) — Formula Systems (1985) Ltd. (NASDAQ and TASE: FORTY) (“Formula” or the […]

Achieved record revenue, Adjusted EBITDA and operating cashflow $47.9 million operating cash inflow in FY24 YTD Quarterly NPAT of $8.6 […]

SYDNEY, Australia, May 15, 2024 (GLOBE NEWSWIRE) — IREN (Iris Energy Limited) (NASDAQ: IREN) (together with its subsidiaries, “IREN” or […]

First Quarter 2024 Highlights Revenue of $364.3 million increased by 20.0% compared to the prior year quarter Patient encounter growth […]

Taipei, Taiwan, May 15, 2024 (GLOBE NEWSWIRE) — Semilux International Ltd. (“Semilux” or the “Company”) (NASDAQ: SELX), today announced that […]

~ Q1 2024 Revenues Increase 27% from Q1 2023 to $4.2 Million ~ ~ Strategic Partnerships Formed with Chartis and […]